JP2023520323A5 - - Google Patents
Info
- Publication number
- JP2023520323A5 JP2023520323A5 JP2022557150A JP2022557150A JP2023520323A5 JP 2023520323 A5 JP2023520323 A5 JP 2023520323A5 JP 2022557150 A JP2022557150 A JP 2022557150A JP 2022557150 A JP2022557150 A JP 2022557150A JP 2023520323 A5 JP2023520323 A5 JP 2023520323A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- compound
- virus
- respiratory
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2004209.9A GB202004209D0 (en) | 2020-03-23 | 2020-03-23 | New use |
| GB2004209.9 | 2020-03-23 | ||
| GB2009574.1 | 2020-06-23 | ||
| GBGB2009574.1A GB202009574D0 (en) | 2020-06-23 | 2020-06-23 | New use |
| US17/113,416 US11123329B1 (en) | 2020-03-23 | 2020-12-07 | Use of angiotensin II type 2 receptor agonist |
| US17/113,416 | 2020-12-07 | ||
| PCT/GB2021/050699 WO2021191592A1 (en) | 2020-03-23 | 2021-03-22 | New use of angiotensin ii type 2 receptor agonist |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023520323A JP2023520323A (ja) | 2023-05-17 |
| JP2023520323A5 true JP2023520323A5 (https=) | 2024-04-03 |
| JP7671305B2 JP7671305B2 (ja) | 2025-05-01 |
Family
ID=77747178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022557150A Active JP7671305B2 (ja) | 2020-03-23 | 2021-03-22 | ２型アンギオテンシンｉｉ受容体アゴニストの新規使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11123329B1 (https=) |
| EP (1) | EP4125881B1 (https=) |
| JP (1) | JP7671305B2 (https=) |
| CN (1) | CN115605201A (https=) |
| CA (1) | CA3176108A1 (https=) |
| ES (1) | ES2992423T3 (https=) |
| HR (1) | HRP20241435T1 (https=) |
| HU (1) | HUE068662T2 (https=) |
| PL (1) | PL4125881T3 (https=) |
| RS (1) | RS66072B1 (https=) |
| SM (1) | SMT202400427T1 (https=) |
| WO (1) | WO2021191592A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202004094D0 (en) * | 2020-03-20 | 2020-05-06 | Vicore Pharma Ab | New compounds and uses |
| US20220233480A1 (en) * | 2020-03-23 | 2022-07-28 | Vicore Pharma Ab | Use of angiotensin ii type 2 receptor agonist |
| AU2021258178A1 (en) * | 2020-04-22 | 2022-11-17 | Airway Therapeutics, Inc. | Use of surfactant protein D to treat viral infections |
| US20240408065A1 (en) * | 2021-09-30 | 2024-12-12 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Cyano compound, and preparation method therefor and use thereof |
| CN115583984A (zh) * | 2022-01-11 | 2023-01-10 | 嘉兴安谛康生物科技有限公司 | 氮杂螺类化合物及其制备方法、药物组合物和用途 |
| CN114948950A (zh) * | 2022-01-19 | 2022-08-30 | 广州谷森制药有限公司 | 一种药物组合物及其抗病毒用途 |
| WO2024153020A1 (zh) * | 2023-01-16 | 2024-07-25 | 海南先声药业有限公司 | 抗病毒药物组合物及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1529697B (zh) | 2001-05-31 | 2010-09-22 | 维科尔药物公司 | 用作血管紧张素ⅱ激动剂的三环化合物 |
| EP1723962A1 (en) | 2005-05-19 | 2006-11-22 | IMBA-Institut für Molekulare Biotechnologie GmbH | Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries |
| EP3265082A1 (en) | 2015-03-02 | 2018-01-10 | Vicore Pharma AB | Angiotensin ii receptor agonist for treating pulmonary fibrosis |
| GB201818164D0 (en) | 2018-11-07 | 2018-12-19 | Vicore Pharma Ab | New composition |
-
2020
- 2020-12-07 US US17/113,416 patent/US11123329B1/en active Active
-
2021
- 2021-03-22 EP EP21715306.3A patent/EP4125881B1/en active Active
- 2021-03-22 WO PCT/GB2021/050699 patent/WO2021191592A1/en not_active Ceased
- 2021-03-22 CA CA3176108A patent/CA3176108A1/en active Pending
- 2021-03-22 SM SM20240427T patent/SMT202400427T1/it unknown
- 2021-03-22 RS RS20241153A patent/RS66072B1/sr unknown
- 2021-03-22 PL PL21715306.3T patent/PL4125881T3/pl unknown
- 2021-03-22 HR HRP20241435TT patent/HRP20241435T1/hr unknown
- 2021-03-22 ES ES21715306T patent/ES2992423T3/es active Active
- 2021-03-22 JP JP2022557150A patent/JP7671305B2/ja active Active
- 2021-03-22 HU HUE21715306A patent/HUE068662T2/hu unknown
- 2021-03-22 CN CN202180035480.3A patent/CN115605201A/zh active Pending
- 2021-08-27 US US17/458,886 patent/US20210386712A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023520323A5 (https=) | ||
| HRP20241435T1 (hr) | Nova upotreba agonista angiotenzinskog ii receptora tipa 2 | |
| CN111297838A (zh) | 一种抗病毒药物的吸入喷雾剂 | |
| CN113304166B (zh) | 核苷类化合物在制备治疗冠状病毒感染性疾病的药物中的用途 | |
| RU2411039C2 (ru) | Иммунокорригирующее средство для лечения заболеваний вирусной этиологии | |
| JP2023547728A5 (https=) | ||
| JP2010270130A5 (https=) | ||
| JP2024504225A5 (https=) | ||
| WO2021203702A1 (zh) | 焦谷氨酸在制备预防和治疗新冠肺炎新型冠状病毒的药物中的应用 | |
| JP2024545086A (ja) | 抗ウイルス治療剤及びその使用 | |
| CN112386595A (zh) | 一种治疗呼吸系统病毒性感染的药物组合物 | |
| JP2025508656A5 (https=) | ||
| AU2009254262B2 (en) | Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes | |
| KR20190009294A (ko) | 비강 울혈을 치료/예방하기 위한 카르복실산 | |
| JP7840570B2 (ja) | コロナウイルス感染症の処置のための方法 | |
| US20030045577A1 (en) | Method for preventing infectious respiratory diseases | |
| JP2002348240A (ja) | 医薬組成物 | |
| WO2016036273A1 (ru) | Лекарственное средство для профилактики и лечения заболеваний дыхательных путей | |
| TW202203946A (zh) | 用於人或動物之慢性或急性之病毒感染症及/或敗血症之預防或治療的組成物 | |
| WO2022199049A1 (zh) | 乌司他丁在制备治疗新型冠状病毒肺炎药物中的用途 | |
| JP2023520929A5 (https=) | ||
| US20220202816A1 (en) | Compositions and methods for treating lung injuries associated with sars-cov-2 infections | |
| WO2019154773A1 (en) | Composition for the prevention and treatment of diseases of the respiratory tract | |
| JP2024543259A5 (https=) | ||
| JPH09227373A (ja) | 抗インフルエンザウイルス剤 |